MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.abb.2025.110318

Медицинская библиотека · Archives of biochemistry and biophysics · 2025

Sivelestat sodium protects against renal ischemia/reperfusion injury by reduction of NETs formation.

Liu Yanqi, Xin Yu, Yuan Mengyao, Liu Yuhan, Song Yuchen, Shen Lifeng, Xiao Yu, Wang Xinran, Wang Dawei, Liu Linqiong, Liu Yuxi, Luo Yinghao, Huang Pengfei, Zhang Qianqian, Zhang Weiting, Li Hongxu, Zhou Yuxin, Wang Xibo, Yu Kaijiang, Wang Changsong

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Ischemia-reperfusion injury (IRI) often results in renal impairment. While the presence of neutrophil extracellular traps (NETs) is consistently observed, their specific impact on IRI is not yet defined. Sivelestat sodium, an inhibitor of neutrophil elastase which is crucial for NET formation, may offer a therapeutic approach to renal IRI, warranting further research.

METHODS

A mouse model was established for early-stage renal IRI, confirmed by injury markers and histological assessments. The involvement of NETs in renal I/R was demonstrated using immunofluorescence and Western blot. Renal function and pathology were further evaluated through a comprehensive set of methods, including Periodic Acid-Schiff staining (PAS) and Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling (TUNEL) staining, enzyme-linked immunosorbent assay (ELISA), Real time Glomerular Filtration Rate (RT-GFR) monitoring, Polymerase Chain Reaction (PCR), biochemical analysis, and additional Western blot and immunofluorescence assays.

RESULTS

We firstly quantified NET expression in renal IRI mice, noting a peak at 24 h. Subsequently, sivelestat sodium treatment was administered, resulting in decreased MPO, CitH3, and attenuated tubular damage. Moreover, it resulted in a decrease in serum levels of creatinine, blood urea nitrogen (BUN), as well as neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1). Additionally, it lowered the abundance of renal tissue inflammatory markers interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), and mitigated the levels of oxidative stress indicators malondialdehyde (MDA) and 4 Hydroxynonenal (4HNE), accompanied by a decline in renal cell apoptosis and an enhancement of GFR in renal I/R mice.

CONCLUSION

Sivelestat sodium ameliorates renal IRI by downregulating neutrophil NETs, reducing inflammation, oxidative stress, and apoptosis, thereby enhancing renal function.

Для цитирования: Liu Yanqi, Xin Yu, Yuan Mengyao, Liu Yuhan, Song Yuchen, Shen Lifeng, Xiao Yu, Wang Xinran, Wang Dawei, Liu Linqiong, Liu Yuxi, Luo Yinghao, Huang Pengfei, Zhang Qianqian, Zhang Weiting, Li Hongxu, Zhou Yuxin, Wang Xibo, Yu Kaijiang, Wang Changsong. Sivelestat sodium protects against renal ischemia/reperfusion injury by reduction of NETs formation.. Archives of biochemistry and biophysics. 2025. DOI: 10.1016/j.abb.2025.110318.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.